"Fetal Development" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Morphological and physiological development of FETUSES.
Descriptor ID |
D047109
|
MeSH Number(s) |
G07.345.500.325.235 G08.686.784.170.157
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fetal Development".
Below are MeSH descriptors whose meaning is more specific than "Fetal Development".
This graph shows the total number of publications written about "Fetal Development" by people in this website by year, and whether "Fetal Development" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2006 | 0 | 2 | 2 |
2007 | 1 | 1 | 2 |
2008 | 2 | 0 | 2 |
2009 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2015 | 1 | 1 | 2 |
2016 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fetal Development" by people in Profiles.
-
Ayala NK, Schlichting LE, Kempner M, Clark MA, Vivier PM, Viner-Brown SI, Werner EF. Association between maternal hypertensive disorders, fetal growth and childhood learning outcomes. Pregnancy Hypertens. 2021 Aug; 25:249-254.
-
Wood ME, Lapane KL, van Gelder MMHJ, Rai D, Nordeng HME. Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control. Pharmacoepidemiol Drug Saf. 2018 02; 27(2):140-147.
-
Lauring JR, Gupta M, Kunselman AR, Repke JT, Pauli JM. Identification of small for gestational age by population-based and customized growth charts in newborns of obese and normal-weight primiparous women. J Matern Fetal Neonatal Med. 2016 Nov; 29(21):3570-4.
-
Sharp AJ, Akbarian S. Back to the past in schizophrenia genomics. Nat Neurosci. 2016 Jan; 19(1):1-2.
-
Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol. 2015 May; 125(5):1224-1235.
-
Deutsch CK, Levy DL, Price SF, Bodkin JA, Boling L, Coleman MJ, Johnson F, Lerbinger J, Matthysse S, Holzman PS. Quantitative Measures of Craniofacial Dysmorphology in a Family Study of Schizophrenia and Bipolar Illness. Schizophr Bull. 2015 Nov; 41(6):1309-16.
-
Schug TT, Erlebacher A, Leibowitz S, Ma L, Muglia LJ, Rando OJ, Rogers JM, Romero R, vom Saal FS, Wise DL. Fetal programming and environmental exposures: implications for prenatal care and preterm birth. Ann N Y Acad Sci. 2012 Dec; 1276:37-46.
-
Calmus ML, Macksoud EE, Tucker R, Iozzo RV, Lechner BE. A mouse model of spontaneous preterm birth based on the genetic ablation of biglycan and decorin. Reproduction. 2011 Jul; 142(1):183-94.
-
Hatch EE, Troisi R, Wise LA, Titus-Ernstoff L, Hyer M, Palmer JR, Strohsnitter WC, Robboy SJ, Anderson D, Kaufman R, Adam E, Hoover RN. Preterm birth, fetal growth, and age at menarche among women exposed prenatally to diethylstilbestrol (DES). Reprod Toxicol. 2011 Feb; 31(2):151-7.
-
Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, Ramin S, Chaudron L, Lockwood C. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009 Sep-Oct; 31(5):403-13.